| Family Solutions Iii, Inc. | |
|
1125 6th St Jesup IA 50648-1105 | |
| (319) 822-7610 | |
| (319) 827-1699 |
| Full Name | Family Solutions Iii, Inc. |
|---|---|
| Speciality | Community/behavioral Health |
| Location | 1125 6th St, Jesup, Iowa |
| Authorized Official Name and Position | Gail M Althaus (EXECUTIVE OFFICER) |
| Authorized Official Contact | 3198276103 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Family Solutions Iii, Inc. 1125 6th St Jesup IA 50648-1105 Ph: (319) 822-7610 | Family Solutions Iii, Inc. 1125 6th St Jesup IA 50648-1105 Ph: (319) 822-7610 |
| NPI Number | 1568655249 |
|---|---|
| Provider Enumeration Date | 08/24/2007 |
| Last Update Date | 08/24/2007 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568655249 | NPI | - | NPPES |
| 000 | Medicaid | IA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 251S00000X | Community/behavioral Health | 00233 (Iowa) | Primary |
News Archive
Dutch researchers report that weather conditions including temperature, sunshine, and precipitation have no impact on fibromyalgia symptoms in female patients. Results published in published in Arthritis Care & Research, a journal of the American College of Rheumatology (ACR), suggest that individual patients may be sensitive to some changes in the weather.
Reflecting the increased need for medical practices and healthcare facilities to streamline patient record processes in order to increase efficiency across a range of insurance and billing functions, Canon U.S.A., Inc., a leader in digital imaging, will showcase an array of workflow simplifying solutions from its innovative imageFORMULA document scanning portfolio, including the new ScanFront 300P network scanner, at the Medical Group Management Association (MGMA) 2010 Annual Conference, October 24-27, 2010 at the Ernest N. Morial Convention Center in New Orleans.
Celldex Therapeutics, Inc. today announced that interim, topline results of the Phase 2b EMERGE study of CDX-011 in patients with advanced breast cancer will be presented in a webcast on May 23, 2012. Linda Vahdat, MD, Professor of Medicine, Chief of Solid Tumor Service and Director of the Breast Cancer Research Program at Weill Cornell Medical College and the lead investigator of the EMERGE study, will join Celldex on the webcast to discuss data from the study.
Cisplatin, an anticancer drug widely used for treating various types of tumor, can induce side effects in the short term. A team of scientists, mostly from CNRS and the Université de Nice has provided first in vitro evidence that this antitumor agent modifies the sensitivity of cellular pressure sensors. This completely novel mechanism could help to elucidate certain neurological side effects of cisplatin hitherto unexplained.
In a long-term study of people infected with the hepatitis C virus (HCV), researchers found increased deaths from both liver-related and non-liver related diseases in patients with active infections who had not cleared their infection.
› Verified 7 days ago